Skip to content
About Us
Team
Board
Business Model
Pipeline
BRM421 for Dry Eye Disease
BRM423 for Corneal Damage Repair
BRM424 for Neurotrophic Keratitis
BRM521 for Treatment of Osteoarthritis
Investors
News
Corporate Governance
Committees
Internal audit
Risk management
Major Internal Policies
Shareholder information
Financial information
Corporate Sustainability
Stakeholders
News
Career
Contact Us
繁體中文
About Us
Team
Board
Business Model
Pipeline
BRM421 for Dry Eye Disease
BRM423 for Corneal Damage Repair
BRM424 for Neurotrophic Keratitis
BRM521 for Treatment of Osteoarthritis
Investors
News
Corporate Governance
Committees
Internal audit
Risk management
Major Internal Policies
Shareholder information
Financial information
Corporate Sustainability
Stakeholders
News
Career
Contact Us
繁體中文
選單
INVESTORS
Shareholder information
BRIM Biotechnology Stock Quotes
BRIM is traded on the Emerging Stock Board at Taipei Exchange (TPEx).
Latest share price information
Shareholder meetings
2022 First Provisional Shareholder Meeting
2022 First Provisional Shareholder Meeting Notice
2022 First Provisional Shareholder Meeting Handbook
2022 First Provisional Shareholder Meeting Minute
2022 General Shareholder Meeting
2022 General Shareholder Meeting Notice
2022 General Shareholder Meeting Handbook
2022 General Shareholder Meeting Minute
2023 First Provisional Shareholder Meeting
2023 First Provisional Shareholder Meeting Notice
2023 First Provisional Shareholder Meeting Handbook
2023 First Provisional Shareholder Meeting Minute
2023 General Shareholder Meeting
2023 General Shareholder Meeting Notice
2023 General Shareholder Meeting Handbook
Annual Reports
2022 Shareholder Meeting Annual Report
2021 Shareholder Meeting Annual Report